GENESIS

Scope & Guideline

Connecting Disciplines, Inspiring Discoveries

Introduction

Welcome to the GENESIS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of GENESIS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1526-954x
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2000 to 2024
AbbreviationGENESIS / Genesis
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'GENESIS' focuses on the intricate biology of blood vessels and endothelial cells, emphasizing their roles in health and disease. It encompasses a broad range of research areas related to vascular biology, angiogenesis, and endothelial function, employing diverse methodologies from molecular biology to advanced imaging techniques.
  1. Vascular Biology and Angiogenesis:
    The journal extensively covers the mechanisms of vascular development and the processes of angiogenesis, including the signaling pathways and cellular interactions that govern these phenomena.
  2. Endothelial Cell Function and Dysfunction:
    Research on the normal and pathological functions of endothelial cells is a core focus, including studies on endothelial barrier integrity, inflammation, and responses to various stimuli.
  3. Molecular Mechanisms in Vascular Diseases:
    The journal highlights the molecular underpinnings of vascular diseases, such as hereditary hemorrhagic telangiectasia, diabetic retinopathy, and the effects of systemic diseases like COVID-19 on endothelial health.
  4. Innovative Therapeutic Approaches:
    There is a consistent emphasis on novel therapeutic strategies targeting the vascular system, including gene therapies, monoclonal antibodies, and small molecules aimed at modulating angiogenesis and endothelial function.
  5. Emerging Technologies in Vascular Research:
    The journal promotes studies utilizing cutting-edge technologies, such as organ-on-a-chip models, CRISPR gene editing, and advanced imaging techniques, to explore vascular biology.
Recent publications in 'GENESIS' reveal several emerging themes and trends that reflect the evolving landscape of vascular biology research. These themes indicate a shift towards understanding complex interactions and therapeutic innovations.
  1. Impact of Systemic Conditions on Endothelial Health:
    Increasing attention is being paid to how systemic diseases, particularly COVID-19, affect endothelial function, highlighting the importance of endothelial health in overall disease outcomes.
  2. Role of Extracellular Vesicles in Angiogenesis:
    Research is emerging on the role of extracellular vesicles in mediating communication between cells in the vascular niche, influencing angiogenesis and vascular remodeling.
  3. Endothelial Cell Plasticity:
    There is a growing interest in the plasticity of endothelial cells, including their ability to adapt to varying physiological and pathological conditions, which is crucial for understanding vascular responses.
  4. Therapeutic Targeting of Angiogenesis:
    A significant trend is the exploration of novel therapeutic targets within angiogenic pathways, including the development of monoclonal antibodies and small molecules aimed at specific vascular mediators.
  5. Integration of Genomics and Vascular Biology:
    The integration of genomic data with vascular biology is becoming increasingly prominent, with studies focusing on genetic predispositions to vascular diseases and the implications of genetic mutations on endothelial function.

Declining or Waning

While the journal continues to grow in many areas, some themes appear to be declining in prominence. This shift may reflect changing research priorities or the maturation of certain lines of inquiry.
  1. Traditional Angiogenesis Models:
    There is a noticeable reduction in studies utilizing classical in vitro models of angiogenesis, such as Matrigel assays, as researchers increasingly turn to more sophisticated systems that better mimic physiological conditions.
  2. Basic Vascular Anatomy Studies:
    Research focused solely on the descriptive aspects of vascular anatomy without functional implications is becoming less frequent, as the field moves towards understanding the dynamic processes involved in vascular function and pathology.
  3. Isolated Disease Studies:
    There is a waning interest in studies that focus exclusively on single diseases without considering the broader implications on vascular biology, as integrated approaches are gaining favor.

Similar Journals

CELL RESEARCH

Connecting Research to Real-World Impact
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Connecting scientists to the forefront of pulmonary physiology.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 1040-0605Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pioneering insights into thrombosis and vascular disorders.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Journal of Molecular Cell Biology

Advancing the frontiers of cellular understanding.
Publisher: OXFORD UNIV PRESSISSN: 1674-2788Frequency: 6 issues/year

The Journal of Molecular Cell Biology, published by Oxford University Press, is a leading platform for groundbreaking research in the fields of cell biology, genetics, and molecular biology. With an impact factor that places it in the Q1 and Q2 quartiles across key academic categories, this journal has become an essential resource for researchers and professionals committed to advancing our understanding of cellular mechanisms and genetic processes. Since becoming Open Access in 2019, it has enhanced the accessibility of high-quality research, fostering collaboration and knowledge sharing within the scientific community. The journal's Scopus rankings reflect its significant impact in the field, particularly in genetics and molecular biology, ranking within the top percentiles. With a convergence of research spanning from 2009 to 2024, the Journal of Molecular Cell Biology remains at the forefront of innovative discoveries and critical discussions, making it a vital resource for students, academics, and industry experts alike.

CELL BIOLOGY INTERNATIONAL

Unveiling the Mysteries of Cellular Mechanisms
Publisher: WILEYISSN: 1065-6995Frequency: 12 issues/year

CELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.

Organogenesis

Unveiling the Complexities of Organogenesis.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

JOURNAL OF VASCULAR RESEARCH

Advancing vascular knowledge since 1964.
Publisher: KARGERISSN: 1018-1172Frequency: 6 issues/year

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Illuminating Cellular Processes Through Open Access Research
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

CURRENT MOLECULAR MEDICINE

Exploring the Molecular Mechanisms of Health and Disease
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1566-5240Frequency: 10 issues/year

CURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.

Cells

Advancing the Frontiers of Cellular Research
Publisher: MDPIISSN: Frequency: 24 issues/year

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.